Cardioneuroablation for Recurrent Vasovagal Syncope and Bradyarrhythmias: The CNA-FWRD Registry

Description

The CNA-FWRD Registry is an international prospective observational multicenter registry of patients with symptomatic vasovagal syncope and bradyarrhythmias managed under routine care by medical therapy and radiofrequency catheter ablation of ganglionated plexi or permanent pacemaker implantation.

Conditions

Vasovagal Syncope, AV Block-2Nd Degree-Type 1, Sinus Pause

Study Overview

Study Details

Study overview

The CNA-FWRD Registry is an international prospective observational multicenter registry of patients with symptomatic vasovagal syncope and bradyarrhythmias managed under routine care by medical therapy and radiofrequency catheter ablation of ganglionated plexi or permanent pacemaker implantation.

Cardioneuroablation for the Management of Patients With Recurrent Vasovagal Syncope and Symptomatic Bradyarrhythmias: The CNA-FWRD Registry

Cardioneuroablation for Recurrent Vasovagal Syncope and Bradyarrhythmias: The CNA-FWRD Registry

Condition
Vasovagal Syncope
Intervention / Treatment

-

Contacts and Locations

Chicago

Rush University Medical Centert, Chicago, Illinois, United States, 60657

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * symptomatic vasovagal syncope or symptomatic bradyarrhythmia refractory to behavioral and medical measures
  • * age \< 60 years
  • * age \> 60 years
  • * intra-/infra-Hisian AV block
  • * intrinsic sinus node disease
  • * history of supraventricular tachycardia
  • * history of ventricular tachycardia
  • * presence of structural heart disease related
  • * prior history of catheter ablation
  • * presence of inheritable arrhythmic conditions
  • * orthostatic hypotension on HUTT test
  • * abnormal thyroid function levels
  • * Proven indication for permanent pacemaker implantation

Ages Eligible for Study

18 Years to 60 Years

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

Rush University Medical Center,

Tolga Aksu, MD, STUDY_CHAIR, Yepedite University

Study Record Dates

2027-04-30